128 filings
Page 3 of 7
8-K
1f8k75ssk7gol5ewvwi9
6 Mar 23
Invivyd Optimizes Development Efficiency with Election of VYD222 for Near-term Clinical
7:42am
8-K
1s1xz ec0652qu5fsihq
9 Jan 23
Other Events
7:11am
8-K
3x9671sx3o jhcdl
6 Dec 22
Departure of Directors or Certain Officers
4:28pm
D
nf9jwjm y2t1hu40mgm
29 Nov 22
$23.75 mm in equity / options / securities to be acquired, sold $23.75 mm, 1 investor
5:16pm
8-K
m5qf1
17 Nov 22
Invivyd Announces Partnership with Population Health Partners to Accelerate Clinical Development In Infectious Diseases Including COVID-19
7:10am
8-K
86kab hrag2gzynng83y
10 Nov 22
Invivyd Reports Third Quarter 2022 Financial Results and Business Highlights
4:13pm
8-K
6his42o acttiu
24 Oct 22
Invivyd Announces the Appointment of Christine Lindenboom to Board of Directors
4:30pm
8-K
1axp5joh wjk
13 Oct 22
Invivyd Appoints Fred Driscoll as Interim Chief Financial Officer and Announces Resource Reallocation to Maximize Integrated Discovery
4:16pm
EFFECT
u8i hfmpk9
6 Oct 22
Notice of effectiveness
12:15am
CORRESP
op5g bo4j1
3 Oct 22
Correspondence with SEC
12:00am
UPLOAD
neu3qqie7
30 Sep 22
Letter from SEC
12:00am
S-3
pxju0lzarhbsg ph7o
28 Sep 22
Shelf registration
5:08pm
8-K
ff0 dlma6nqv31
13 Sep 22
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
065xzo3
12 Sep 22
Adagio Therapeutics Announces Corporate Name Change to Invivyd
7:46am
8-K
0iq4nrq41 1jse1m1hc
15 Aug 22
Adagio Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
7:22am
8-K
9y6izl9 y4
5 Jul 22
Adagio Announces Results of Annual Meeting of Stockholders and Evolution of the Board of Directors
4:41pm
8-K
zxg fs1hu6lgn7609oh
30 Jun 22
Departure of Directors or Certain Officers
4:30pm
8-K
ynzq84vlnmlz10n
22 Jun 22
Submission of Matters to a Vote of Security Holders
5:18pm